Mark J. Adler, M.D.

Mark J. Adler, M.D. Email and Phone Number

Director Genomic Oncology (SDCRI) @ Forian Inc.
Mark J. Adler, M.D.'s Location
San Diego County, California, United States, United States
About Mark J. Adler, M.D.

Training: Medical Oncologist: B.A. Yale, M.D. Univ. of Penn., Univ. of PENN residency Internal Medicine, Oncology sub-specialty board: UCSD Cancer Center. Tumor Immunology fellowship at Wistar Institute 1985-86NIH Physician-Scientist Award 1986-1990 Career MilestonesFounder and CEO of SDCC (San Diego Cancer Center)1991 until acquisition by UCSD 2011 Director, UC San Diego Cancer Center, after acquisition by UC RegentsCEO Internal Medicine Group 1993 until acquisition 2011 by UC San Diego Medical Group. Director of Strategy UCSD Oncology 2011 until 2014 Chair SAB 2015-present Strategic Advisor to CEO 2015-19 Biological DynamicsDirector of Genomic Oncology at San Diego Cancer Research Institute 501c3: 1994-presentPUBLIC COMPANY Board of Directors:WebMD: Director on Board 19 years from inception of public company, predecessor and subsidiary companies, most notably Medscape--premier online resources for physician education.CareInsite (CARI: NASDAQ) BODHLTH (NASDAQ): BODSYNETIC (NASDAQ): BODADVISORY ROLESCHAIR ADVISORY BOARD: Biological Dynamics: company has multi-purpose platform to separate specified range of macromolecules from blood. Proprietary method uses alternating current to isolate circulating cell-free DNA from blood. Efforts underway to establish clinical validation as a general platform lab tool and to develop pan-cancer early cancer screen for general public.ADVISORY BOARD AutogenomicsCareer is mosaic of clinical oncology, Directorship roles leading cancer centers, Board of Director roles at 4 public companies, scientific/medical advisory, and consultation roles. Chair Advisory Board of start-up Biological DynamicsDirector of Genomic Oncology and Institute Director, San Diego Cancer Research Institute 501c3

Mark J. Adler, M.D.'s Current Company Details
Forian Inc.

Forian Inc.

View
Director Genomic Oncology (SDCRI)
Mark J. Adler, M.D. Work Experience Details
  • Forian Inc.
    Director
    Forian Inc. Jan 2020 - Present
    Newtown, Pennsylvania, Us
    application of informatics to Big Data
  • Self-Employed
    Clinical And Molecular Oncologist (Diplomat Nih Physician-Scientist Award)
    Self-Employed Jan 2014 - Present
  • San Diego Cancer Research Institute 501C3
    Director Genomic Oncology
    San Diego Cancer Research Institute 501C3 2003 - Present
    Studies on the genetic basis of cancer and early detection tests
  • San Diego Cancer Research Institute
    Institute Director
    San Diego Cancer Research Institute Jun 2004 - Present
    Vista, California, Us
  • Biological Dynamics
    Chair Scientific Advisory Board
    Biological Dynamics Jan 2010 - Present
    Application of novel technology to detect circulating cell-free tumor DNA as means of monitoring cancer
  • Self-Employed
    Molecular Oncologist
    Self-Employed Jan 1990 - Present
  • Webmd
    Director Webmd
    Webmd 1998 - 2017
    Us
    Director on Board of WebMD and of predecessor companies including Director CareInsite (CARI: Nasdaq), Director HLTH (HLTH; Nasdaq), DirectorEMDEON (Nasdaq), Director SYNETIC (Nasdaq), Director Medical Manager (Nasdaq)
  • Genotyping-Autogenomics
    Scientific Advisory Board
    Genotyping-Autogenomics Jan 2007 - May 2014
    translational oncology using molecular genomic testsdevelopment test pan-cancer screen general populationadvisory board Chair and memberBoard of Director several public companies
  • Uc San Diego Health
    Director Strategic Development
    Uc San Diego Health Feb 2011 - Feb 2014
    San Diego, Ca, Us
  • Uc San Diego Health
    Clinical Adjunct Associate Professor
    Uc San Diego Health Jun 1987 - Feb 2014
    San Diego, Ca, Us
    Co-Founder and former CEO SDCC (Now UC San Diego Cancer Centers)
  • Ucsd
    Molecular Biology Of Cancer (Diplomat Nih Physician Scientist Award)
    Ucsd Jan 1987 - Feb 2014
    Studies molecular intereraction between oncogenes and in vitro cellular senescence
  • Uc San Diego Health System-Encinitas Cancer
    Co-Founder And Former Ceo
    Uc San Diego Health System-Encinitas Cancer Jun 1993 - Feb 2011
    Founder and CEO

Mark J. Adler, M.D. Education Details

  • Yale University
    Yale University
    Philosophy
  • Yale University  Summa Cum Laude
    Yale University Summa Cum Laude
    Special Divisional Major: Philosophy And Neurophysiology
  • University Of Pennsylvania
    University Of Pennsylvania
    Doctor Of Medicine (M.D.)
  • Uc San Diego
    Uc San Diego
    Medical Oncology
  • Wistar Institute
    Wistar Institute
    Tumor Immunology
  • Nih Physician Scientist Awardee
    Nih Physician Scientist Awardee
    Molecular Biology Of Cancer
  • University Of Pennsylvania
    University Of Pennsylvania
    Research Myelin At Chop
  • University Of Pennsylvania
    University Of Pennsylvania
    Doctor Of Medicine - Md

Frequently Asked Questions about Mark J. Adler, M.D.

What company does Mark J. Adler, M.D. work for?

Mark J. Adler, M.D. works for Forian Inc.

What is Mark J. Adler, M.D.'s role at the current company?

Mark J. Adler, M.D.'s current role is Director Genomic Oncology (SDCRI).

What schools did Mark J. Adler, M.D. attend?

Mark J. Adler, M.D. attended Yale University, Yale University Summa Cum Laude, University Of Pennsylvania, Uc San Diego, Wistar Institute, Nih Physician Scientist Awardee, University Of Pennsylvania, University Of Pennsylvania.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.